P. Biessels

A comparison of the pharmacological actions of 4-aminopyridine and two of its derivatives in the monkey.

M. Houwertjes, A. Horn, S. Ágoston, 1985, European journal of pharmacology.

Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti‐viral activity†

R. Gorczynski, Williams He, I. McGilvray, 2006, Hepatology.

The action of some new aminopyridines on mammalian non-myelinated nerve fibres.

J. van den Akker, A. Horn, S. Ágoston, 1983, European journal of pharmacology.

Detection of erythrocyte membrane components in hemoglobin-based blood substitutes.

G. Berbers, W. Bleeker, H. Huisman, 1992, Clinica chimica acta; international journal of clinical chemistry.

Detection of membrane fragments in hemoglobin solutions.

G. Berbers, W. Bleeker, J. Huisman, 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

Approaches to analogues of anhydrogliotoxin V Syntheses of monodesthio‐secogliotoxin analogues

H. Ottenheijm, P. Biessels, J. Hoffmann, 2010 .

Comparison of the pharmacological actions of some new 4-aminopyridine derivatives.

A. Horn, S. Ágoston, P. Biessels, 1984, European journal of pharmacology.

Function of isolated rabbit hearts perfused with erythrocyte suspension is not stable but improvement may be feasible with hemoglobin solution.

J. V. van Beek, N. Westerhof, J. Bakker, 1994, Advances in Experimental Medicine and Biology.

Effects of modified hemoglobin solutions on the isolated rabbit heart.

J. V. van Beek, W. Bleeker, J. Hak, 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

The effect of some new aminopyridines on mammalian non-myelinated nerve fibres.

S. Ágoston, A. den Hertog, P. Biessels, 1983, European journal of pharmacology.

Preparation and characterization of crosslinked and polymerized hemoglobin solutions.

G. Berbers, W. Bleeker, P. J. den Boer, 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.

P. Lenting, J. V. van Mourik, J. Voorberg, 1995, The Biochemical journal.

Chapter 18 – Safety and Efficacy of Hemoglobin Modified by Crosslinking or Polymerization

W. Bleeker, A. Trouwborst, M. Iterson, 1998 .

Measurement of interleukin-6 production by monocytes for in vitro safety testing of hemoglobin solutions.

L. Aarden, W. Bleeker, P. J. den Boer, 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

Prevention of side effects by hemoglobin solutions; the selection of optimal test models, especially concerning thrombogenicity.

W. Bleeker, K. Mertens, J. Holthuis, 1994, Artificial cells, blood substitutes, and immobilization biotechnology.